You are here

  • Home
  • Archive
  • Volume 71, Issue 4
  • Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

Article metrics

Article menu
Stomach
Original research
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 202117251684419
Jun 2021624605216
Jul 2021388365141
Aug 2021248228104
Sep 202120518779
Oct 202118217084
Nov 202122520988
Dec 202122321841
Jan 202225924981
Feb 202217916873
Mar 2022620600183
Apr 2022624480148
May 2022372291106
Jun 202230227376
Jul 202215913643
Aug 20221419951
Sep 202219215456
Oct 202218016370
Nov 202214411752
Dec 202214212035
Jan 202315913061
Feb 202316314065
Mar 202315912181
Apr 20231229275
May 202312710169
Jun 20231008536
Jul 202312210469
Aug 20231199958
Sep 202317816798
Oct 2023277262116
Nov 202337736681
Dec 2023876055
Jan 20244667554
Feb 2024827146
Mar 20241169685
Total978884853195